{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:35:41Z","timestamp":1782891341970,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jchromb.2018.04.020","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T12:35:13Z","timestamp":1523363713000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["High-performance thin-layer chromatographic methods for the determination of febuxostat and febuxostat\/diclofenac combination in human plasma"],"prefix":"10.1016","volume":"1086","author":[{"given":"Fawzi A.","family":"El-Yazbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omayma A.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5922-862X","authenticated-orcid":false,"given":"Eman I.","family":"El-Kimary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam F.","family":"Khamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh E.","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2018.04.020_bb0005","doi-asserted-by":"crossref","first-page":"ii15","DOI":"10.1093\/rheumatology\/kep088","article-title":"Febuxostat: a new treatment for hyperuricaemia in gout","volume":"48","author":"Edwards","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0010","unstructured":"Uloric\u00ae product monograph, Takeda Canada Inc., Ontario, 2016. https:\/\/www.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2011%2F021856s003lbl.pdf&usg=AOvVaw35O6XPE1n1ZtzgaqXmnfgy (accessed July 2017)."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0015","series-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2011"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0020","unstructured":"Diclofenac Potassium 50\u202fmg Film-coated Tablets\u00ae summary of product characteristics, health products regulatory authority, Dublin, 2017. https:\/\/www.hpra.ie%2Fimg%2Fuploaded%2Fswedocuments%2FLicenseSPC_PA1380078002_08092017140037.pdf&usg=AOvVaw2fz2Noaflgu0RMHWCZnL9h (accessed July 2017)."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0025","series-title":"The British Pharmacopeia","year":"2016"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0030","series-title":"The European Pharmacopeia","year":"2014"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0035","series-title":"The United States Pharmacopeia Thirty Third Ed., The National Formulary Twenty Eighth Ed.","year":"2011"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0040","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2174\/157341101004140701115811","article-title":"Development and validation of a sensitive HPLC-MS\/MS-ESI method for determination of febuxostat: application to pharmacokinetic study","volume":"10","author":"Choudhury","year":"2014","journal-title":"Curr. Anal. Chem."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0045","first-page":"354","article-title":"Determination of febuxostat in human plasma by LC-MS-MS","volume":"32","author":"Jiang","year":"2014","journal-title":"Yaoxue Shijian Zazhi"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0050","first-page":"811","article-title":"Determination of febuxostat in human plasma by LC-MS\/MS","volume":"32","author":"Long","year":"2013","journal-title":"Zhongguo Xinyao Yu Linchuang Zazhi"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0055","first-page":"396","article-title":"Development of a simple LC-MS\/MS method for the determination of febuxostat in human plasma and its application to a bioequivalence study","volume":"68","author":"Shi","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0060","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/bmc.2936","article-title":"A sensitive LC-MS\/MS method for the quantification of febuxostat in human plasma and its pharmacokinetic application","volume":"27","author":"Vaka","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/bmc.2744","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of febuxostat in human plasma","volume":"27","author":"Wang","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/dta.420","article-title":"Determination of febuxostat in human plasma using ultra-performance liquid chromatography tandem mass spectrometry","volume":"5","author":"Lukram","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0075","first-page":"1148","article-title":"Determination of the contents of febuxostat in human plasma by HPLC-FLU and studies on its pharmacokinetics","volume":"16","author":"Zhang","year":"2011","journal-title":"Zhongguo Linchuang Yaolixue Yu Zhiliaoxue"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0080","doi-asserted-by":"crossref","first-page":"73432","DOI":"10.1039\/C6RA11246C","article-title":"Specific and highly sensitive spectrofluorimetric method for determination of febuxostat in its tablets and real human plasma. Application to stability studies","volume":"6","author":"Omar","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.talanta.2017.08.051","article-title":"Innovative thin-layer chromatographic method combined with fluorescence detection for specific determination of Febuxostat: application in biological fluids","volume":"176","author":"Mohamed","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0090","first-page":"1671","article-title":"Pharmacokinetic and bioequivalence studies of immediate release diclofenac potassium tablets (50mg) in healthy volunteers","volume":"29","author":"Ali","year":"2016","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0095","first-page":"566","article-title":"Comparative in vitro dissolution and in vivo bioequivalence of two diclofenac enteric coated formulations","volume":"61","author":"Basmenji","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/bmc.537","article-title":"Determination of diclofenac in plasma by high-performance liquid chromatography with electrochemical detection","volume":"20","author":"Chmielewska","year":"2006","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0105","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/chromsci\/bms026","article-title":"Simultaneous determination of diclofenac potassium and drotaverine hydrochloride in human plasma using reversed-phase high-performance liquid chromatography","volume":"50","author":"Dahivelkar","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0110","first-page":"622","article-title":"Development and validation of a HPLC method for in-vivo study of diclofenac potassium","volume":"4","author":"El Degwy","year":"2013","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0115","first-page":"248","article-title":"In vitro and in vivo evaluation of diclofenac potassium lyophilized orally disintegrating tablets","volume":"4","author":"El Degwy","year":"2013","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0120","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1185\/03007990903158513","article-title":"Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers","volume":"25","author":"Lissy","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0125","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/chrsci\/49.6.422","article-title":"HPLC method for determination of diclofenac in human plasma and its application to a pharmacokinetic study in Turkey","volume":"49","author":"Yilmaz","year":"2011","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0130","series-title":"Guidance for Industry: Bioanalytical Method Validation","year":"2013"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0135","series-title":"High-performance Thin-layer Chromatography (HPTLC)","author":"Srivastava","year":"2011"},{"key":"10.1016\/j.jchromb.2018.04.020_bb0140","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1124\/dmd.110.037622","article-title":"Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport","volume":"39","author":"Kindla","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2018.04.020_bb0145","series-title":"Hydrochloric Acid (Hydrogen Chloride): Hazard Summary","year":"2000"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217321098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217321098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T12:41:52Z","timestamp":1552999312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023217321098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":29,"alternative-id":["S1570023217321098"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.04.020","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-performance thin-layer chromatographic methods for the determination of febuxostat and febuxostat\/diclofenac combination in human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}